Document Detail


A new face of endocannabinoids in pharmacotherapy. Part I: Protective role of endocannabinoids in hypertension and myocardial infarction.
MedLine Citation:
PMID:  24781727     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Cannabinoids are compounds which were first isolated from the Cannabis sativa plant. For thousands of years they have been used for treatment of numerous diseases. Currently, synthetic cannabinoids and endocannabinoids are also known. Cannabinoid receptors, endocannabinoids and the enzymes that catalyze their synthesis and degradation constitute the endocannabinoid system which plays an important role in functioning of the cardiovascular system. The results obtained to date suggest the involvement of endocannabinoids in the pathology of many cardiovascular diseases, including myocardial infarction, hypertension and hypotension associated with hemorrhagic, endotoxic, and cardiogenic shock. Cardioprotective effect and dilation of coronary vessels induced by endocannabinoids deserve special attention. It cannot be excluded now that in the future our better understanding of cannabinoid system will allow to develop new strategies for treatment of cardiovascular diseases.
Authors:
M Zubrzycki; A Liebold; A Janecka; M Zubrzycka
Related Documents :
15608107 - Comparison of cardiac output determined by bioimpedance, thermodilution, and the fick m...
983937 - Spontaneous cardiac tamponade due to sternotomy wire suture.
11861347 - Ketamine anesthesia for pericardial window in a patient with pericardial tamponade and ...
536827 - A dynamic phantom for radionuclide cardiology.
16261287 - A randomized, double-blind, placebo-controlled study of the safety and efficacy of intr...
9685937 - Prevention of cerebral vasospasm by vasodilatory peptide maxadilan following subarachno...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society     Volume:  65     ISSN:  1899-1505     ISO Abbreviation:  J. Physiol. Pharmacol.     Publication Date:  2014 Apr 
Date Detail:
Created Date:  2014-04-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9114501     Medline TA:  J Physiol Pharmacol     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  171-81     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In vivo models for cancer stem cell research: a practical guide for frequently used animal models an...
Next Document:  A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation...